UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000028405
Receipt No. R000031915
Scientific Title Phase 1b investigator initiated trial of combination therapy of Metformin and Nivolumab in participants with advanced or recurrent solid cancer.
Date of disclosure of the study information 2017/07/27
Last modified on 2020/07/28 11:21:35

No. Disposal Last modified on Item of update
1 Insert 2017/07/27 16:47:25
2 Update 2017/08/30 17:13:30 Recruitment status
Anticipated trial start date
3 Update 2019/06/03 10:14:46 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Address
Address
Address
Address
Organization
Organization
Address
Address
Tel
Email
4 Update 2019/06/03 10:18:29 Date of IRB
Last follow-up date
5 Update 2019/07/09 09:09:47 Condition
6 Update 2019/07/09 09:16:23 Key exclusion criteria
7 Update 2019/07/09 09:21:15 Condition
8 Update 2019/07/09 09:23:05 Key exclusion criteria
9 Update 2019/10/29 13:11:07 Key exclusion criteria
Key exclusion criteria
10 Update 2020/01/28 11:07:57 Key secondary outcomes
Key secondary outcomes
11 Update 2020/07/28 11:20:44 Recruitment status
12 Update 2020/07/28 11:21:35 Number of participants that the trial has enrolled


Contact us.